Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”

키워드

참고문헌 (13)

1. Polaris Observatory Collaborators, "Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016 : a modelling study", Lancet Gastroenterol Hepatol, 3, pp.383~403 (2018)
2. Yang HC, "Revisiting the natural history of chronic hepatitis B infection", Clin Liver Dis(Hoboken), 23, pp.e0195~ (2024)
3. Korean Association for the Study of the Liver(KASL), "KASL clinical practice guidelines for management of chronic hepatitis B", Clin Mol Hepatol, 28, pp.276~331 (2022)
4. Tang LSY, "Chronic hepatitis B infection : A review", JAMA, 319, pp.1802~1813 (2018)
5. Lok AS, "Antiviral therapy for chronic hepatitis B viral infection in adults : A systematic review and meta-analysis", Hepatology, 63, pp.284~306 (2016)
6. Choi J, "Risk of hepatocellular carcinoma in patients treated with entecavir vs tenofovir for chronic hepatitis B : A Korean nationwide cohort study", JAMA Oncol, 5, pp.30~36 (2019)
7. Lee SW, "Entecavir versus tenofovir in patients with chronic hepatitis B : Enemies or partners in the prevention of hepatocellular carcinoma", Clin Mol Hepatol, 27, pp.402~412 (2021)
8. Hong CY, "Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection : A nationwide cohort study", J Viral Hepat, 27, pp.896~903 (2020)
9. Fwu CW, "Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma : a cohort study of parous women in Taiwan", Hepatology, 53, pp.1217~1225 (2011)
10. Tan R, "The association of HBV infection and head and neck cancer : a systematic review and meta-analysis", BMC Cancer, 24, pp.225~ (2024)
11. Lee DH, "Association of chronic hepatitis B infection and antiviral treatment with the development of the extrahepatic malignancies : A nationwide cohort study", J Clin Oncol, 40, pp.3394~3405 (2022)
12. Hur MH, "Extrahepatic malignancies and antiviral drugs for chronic hepatitis B : A nationwide cohort study", Clin Mol Hepatol, 30, pp.500~514 (2024)
13. Chon YE, "Extrahepatic malignancies are the leading cause of death in patients with chronic hepatitis B without cirrhosis : A large population-based cohort study", Cancers(Basel), 16, pp.711~ (2024)